127 related articles for article (PubMed ID: 38144572)
1. High incidence of occult familial
Guha A; Vicha A; Zelinka T; Kana M; Musil Z; Pacak K; Betka J; Chovanec M; Plzak J; Boucek J
Front Endocrinol (Lausanne); 2023; 14():1278175. PubMed ID: 38144572
[TBL] [Abstract][Full Text] [Related]
2. Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas.
Wang CP; Chen TC; Chang YL; Ko JY; Yang TL; Lo FY; Hu YL; Chen PL; Wu CC; Lou PJ
Oral Oncol; 2012 Feb; 48(2):125-9. PubMed ID: 21945342
[TBL] [Abstract][Full Text] [Related]
3. Germline mutations and genotype-phenotype associations in head and neck paraganglioma patients with negative family history in China.
Zhu WD; Wang ZY; Chai YC; Wang XW; Chen DY; Wu H
Eur J Med Genet; 2015 Sep; 58(9):433-8. PubMed ID: 26096992
[TBL] [Abstract][Full Text] [Related]
4. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
[TBL] [Abstract][Full Text] [Related]
5. Genetic and clinical characteristics of head and neck paragangliomas in a Chinese population.
Zheng X; Wei S; Yu Y; Xia T; Zhao J; Gao S; Li Y; Gao M
Laryngoscope; 2012 Aug; 122(8):1761-6. PubMed ID: 22566157
[TBL] [Abstract][Full Text] [Related]
6. No difference in phenotype of the main Dutch SDHD founder mutations.
van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
8. Hereditary paraganglioma due to the SDHD M1I mutation in a second Chinese family: a founder effect?
Lee SC; Chionh SB; Chong SM; Taschner PE
Laryngoscope; 2003 Jun; 113(6):1055-8. PubMed ID: 12782822
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.
McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.
Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X
Diagn Mol Pathol; 2005 Jun; 14(2):109-14. PubMed ID: 15905695
[TBL] [Abstract][Full Text] [Related]
12. The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.
Hensen EF; Jansen JC; Siemers MD; Oosterwijk JC; Vriends AH; Corssmit EP; Bayley JP; van der Mey AG; Cornelisse CJ; Devilee P
Eur J Hum Genet; 2010 Jan; 18(1):62-6. PubMed ID: 19584903
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
van Nederveen FH; Gaal J; Favier J; Korpershoek E; Oldenburg RA; de Bruyn EM; Sleddens HF; Derkx P; Rivière J; Dannenberg H; Petri BJ; Komminoth P; Pacak K; Hop WC; Pollard PJ; Mannelli M; Bayley JP; Perren A; Niemann S; Verhofstad AA; de Bruïne AP; Maher ER; Tissier F; Méatchi T; Badoual C; Bertherat J; Amar L; Alataki D; Van Marck E; Ferrau F; François J; de Herder WW; Peeters MP; van Linge A; Lenders JW; Gimenez-Roqueplo AP; de Krijger RR; Dinjens WN
Lancet Oncol; 2009 Aug; 10(8):764-71. PubMed ID: 19576851
[TBL] [Abstract][Full Text] [Related]
14. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH
Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
16. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
17. Paraganglioma of the Head and Neck: A Review.
Sandow L; Thawani R; Kim MS; Heinrich MC
Endocr Pract; 2023 Feb; 29(2):141-147. PubMed ID: 36252779
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
[TBL] [Abstract][Full Text] [Related]
20. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
